Hsinchu, Taiwan

Yi-Chun Lin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gwo XI Stem Cell Applied Technology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi-Chun Lin. Retrieved from https://idiyas.com/inventor/yi-chun-lin-i9sek3tc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yi-Chun Lin: Innovator in Liver Cirrhosis Treatment

Introduction

Yi-Chun Lin is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical technology, particularly in the treatment of liver cirrhosis. His innovative approach utilizes advanced biological techniques to address this serious health condition.

Latest Patents

Yi-Chun Lin holds a patent for a method of treating liver cirrhosis. The patent, titled "Method for treating liver cirrhosis by using composition comprising mesenchymal stem cell, extracellular vesicle produced by mesenchymal stem cell, and growth factor," outlines a composition that includes mesenchymal stem cells, extracellular vesicles produced by these cells, and growth factors. This method has shown promising results in various efficacy experiments aimed at treating liver cirrhosis.

Career Highlights

Yi-Chun Lin is associated with Gwo XI Stem Cell Applied Technology Co., Ltd., where he applies his expertise in stem cell technology. His work focuses on developing innovative solutions for complex medical issues, particularly those related to liver health.

Collaborations

Some of his notable coworkers include Po-Cheng Lin and Pi-chun Huang, who contribute to the collaborative efforts in advancing stem cell research and applications.

Conclusion

Yi-Chun Lin's contributions to the treatment of liver cirrhosis through innovative methods highlight the potential of stem cell technology in modern medicine. His work continues to pave the way for new therapeutic approaches in the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…